|




Feuding antibodies blocked HIV vaccine


Feuding antibodies blocked HIV vaccine

WASHINGTON — US researchers said Monday that a high-profile HIV vaccine trial that was shown to work in just under a third of patients may have been hindered by feuding antibodies. The vaccine trial, known as RV144, involved more than 16,000 HIV ...

Top stories of the last 30 days

AI and the far-right riots in the UK

Whose Pride is it, anyway?